These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2167039)

  • 1. In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.
    Polas PJ; Swenson CL; Sams R; Cheney CM; Hayes KA; Tarr MJ; Kociba GJ; Mathes LE
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1414-21. PubMed ID: 2167039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy.
    Hoover EA; Zeidner NS; Perigo NA; Quackenbush SL; Strobel JD; Hill DL; Mullins JI
    Intervirology; 1989; 30 Suppl 1():12-25. PubMed ID: 2540109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antiviral activity and toxicity of dextran sulfate in feline leukemia virus-infected cats.
    Mathes LE; Hayes KA; Swenson CL; Polas PJ; Weisbrode SE; Kociba GJ
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2147-50. PubMed ID: 1662026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2',3'-dideoxycytidine.
    Zeidner NS; Strobel JD; Perigo NA; Hill DL; Mullins JI; Hoover EA
    Antiviral Res; 1989 Apr; 11(3):147-60. PubMed ID: 2544137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and postexposure chemoprophylaxis: evidence that 3'-azido-3'-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response.
    Mathes LE; Polas PJ; Hayes KA; Swenson CL; Johnson S; Kociba GJ
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2715-21. PubMed ID: 1336345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine toxicity to cats infected with feline leukemia virus.
    Haschek WM; Weigel RM; Scherba G; DeVera MC; Feinmehl R; Solter P; Tompkins MB; Tompkins WA
    Fundam Appl Toxicol; 1990 May; 14(4):764-75. PubMed ID: 2163339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro.
    Swenson CL; Polas PJ; Cheney CM; Kociba GJ; Mathes LE
    Am J Vet Res; 1991 Dec; 52(12):2010-5. PubMed ID: 1724122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
    Hoover EA; Olsen RG; Mathes LE; Schaller JP
    Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of latent feline leukaemia virus infection.
    Rojko JL; Hoover EA; Quackenbush SL; Olsen RG
    Nature; 1982 Jul; 298(5872):385-8. PubMed ID: 6283387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early therapy of feline leukemia virus infection (FeLV-FAIDS) with 9-(2-phosphonylmethoxyethyl)adenine (PMEA).
    Hoover EA; Ebner JP; Zeidner NS; Mullins JI
    Antiviral Res; 1991 Jul; 16(1):77-92. PubMed ID: 1663730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS).
    Zeidner NS; Rose LM; Mathiason-DuBard CK; Myles MH; Hill DL; Mullins JI; Hoover EA
    J Acquir Immune Defic Syndr (1988); 1990; 3(8):787-96. PubMed ID: 2164083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an inactivated FeLV vaccine compared to a recombinant FeLV vaccine in minimum age cats following virulent FeLV challenge.
    Stuke K; King V; Southwick K; Stoeva MI; Thomas A; Winkler MT
    Vaccine; 2014 May; 32(22):2599-603. PubMed ID: 24662705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The location in cartilage of infectious retrovirus in cats infected with feline leukemia virus.
    Arnoczky SP; Swenson C; Egerbacher M; Gardner K; Caballero O; Burns M
    J Bone Joint Surg Am; 2007 Sep; 89(9):2030-6. PubMed ID: 17768202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral efficacy of a 98% solution of glycerol or ethylene oxide for inactivation of feline leukemia virus in bone.
    Coronado GS; Swenson CL
    Am J Vet Res; 2004 Apr; 65(4):436-9. PubMed ID: 15077685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing of nucleoside analogues in cats infected with feline leukemia virus: a model.
    Tavares L; Roneker C; Postie L; de Noronha F
    Intervirology; 1989; 30 Suppl 1():26-35. PubMed ID: 2540111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo infection of marrow stromal fibroblasts by feline leukemia virus.
    Linenberger ML; Abkowitz JL
    Exp Hematol; 1992 Sep; 20(8):1022-7. PubMed ID: 1324184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression.
    Patel M; Carritt K; Lane J; Jayappa H; Stahl M; Bourgeois M
    Clin Vaccine Immunol; 2015 Jul; 22(7):798-805. PubMed ID: 25972402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral therapy in cats progressively infected with feline leukaemia virus: lessons from a series of 18 consecutive cases from Australia.
    Westman ME; Hall E; Norris JM; Meili T; Hofmann-Lehmann R; Malik R
    Aust Vet J; 2024 Sep; 102(9):453-465. PubMed ID: 39042044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
    Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
    Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.